3.6(top 4%)
Impact Factor
3.8(top 4%)
extended IF
80(top 5%)
H-Index
3.4K
authors
3.4K
papers
48.6K
citations
4.8K
citing journals
43.9K
citing authors

Most Cited Articles of Future Oncology

TitleYearCitations
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer2010643
Fatty acid synthase as a potential therapeutic target in cancer2010383
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth2010280
Epithelial-mesenchymal transition in hepatocellular carcinoma2009261
Impact of stress on cancer metastasis2010251
Thyroid cancer gender disparity2010249
Mechanisms of the epithelial-mesenchymal transition by TGF-beta2009238
Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance2010235
Role of gemcitabine in cancer therapy2005213
Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation2010211
Nanoscale radiotherapy with hafnium oxide nanoparticles2012210
The global breast cancer burden2012204
Tumor acidity, chemoresistance and proton pump inhibitors2005189
Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer2011187
New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents2009176
OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma2010174
Cancer biomarkers: knowing the present and predicting the future2005174
Role of hypoxia-inducible factors in breast cancer metastasis2013173
Pancreatic cancer: yesterday, today and tomorrow2016167
Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma2011162
The TGF-beta paradox in human cancer: an update2009160
An overview of meningiomas2018141
Chemotherapy-induced damage to ovary: mechanisms and clinical impact2016137
Mechanisms of acquired resistance to targeted cancer therapies2012135
Novel insights and therapeutic interventions for pediatric osteosarcoma2017130